Vasopressin: its role in antipyresis and febrile convulsion.
When pyrogenic substances are injected intravenously into experimental animals, a sequence of events is set in motion which involves the hypothalamus and perhaps other portions of the diencephalon to produce a febrile response. We now present evidence that the brain produces its own endogenous antipyretic which may serve as a means of controlling the extent of the fever. When arginine vasopressin is perfused through the lateral septal area of the hypothalamus of the sheep, fever is suppressed. Vasopressin alone does not lower normal body temperature when perfused through this region of the brain. In addition, evidence is provided to indicate that vasopressin is released within the lateral septal area during the febrile response. It is concluded that, in fever, arginine vasopressin may be released in the lateral septal area of the brain and serve as an endogenous antipyretic. Results indicate that, following an initial application of vasopressin into the brain itself, a subsequent similar administration of vasopressin produces seizure-like activity. Therefore, it is suggested that this release of arginine vasopressin may contribute to the production of febrile convulsion.
D000818:Animals; D000831:Animals, Newborn; D001127:Arginine Vasopressin / Q000502:physiology; D001833:Body Temperature Regulation / Q000187:drug effects; D005260:Female; D005334:Fever / Q000503:physiopathology; D006168:Guinea Pigs; D007031:Hypothalamus / Q000503:physiopathology; D011247:Pregnancy; D011749:Pyrogens / Q000494:pharmacology; D051381:Rats; D003294:Seizures, Febrile / Q000503:physiopathology*; D012688:Septum Pellucidum / Q000503:physiopathology; D012756:Sheep; D014667:Vasopressins / Q000502:physiology*
D011749:Pyrogens; D014667:Vasopressins; D001127:Arginine Vasopressin